Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06634173
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2023-09-20
Brief Title:
The Diagnostic Value of FAPI PETCT in Staging of Newly Diagnosed Prostate Cancer
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The Diagnostic Value of FAPI PETCT in Staging of Newly Diagnosed Prostate Cancer
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
proFAPI
Brief Summary:
This study aims to investigate the diagnostic value of FAPI PETCT relative to standard-of-care imaging using PSMA PETCT in staging of newly diagnosed PCa FAPI PETCT will be visually and quantitatively correlated to PSMA PETCT resulting in detection rates and target-to-background ratios If available histopathology of resected specimens will serve as reference test for operated patients in order to determine diagnostic accuracy All outcomes are descriptive and serve as pilot for a potential subsequent larger prospective diagnostic study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None